Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Pediatric Studies Characteristics - Detail
  • Print
  • Share
  • E-mail
-
 
Approval Date:  02/21/2008
 
Trade Name:  Humira
 
Generic or Proper Name (*):  adalimumab
 
Indications Studied:  Treatment of juvenile idiopathic arthritis
 
Therapeutic Category:  Anti-inflammatory
 
Ages Studied:  4 years and older
 
Study #:  1
 
Study Type:  Efficacy/Safety/Pharmacokinetic
 
Study Design:  Open Label/Blind/Placebo/Parallel Group/Population Pharmacokinetic
 
No Patients:  171
 
No Centers:  31
 
No Countries:  8
 
BPCA(B), PREA(P):  P
 
-
-